查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1427191

全球數位疫苗市場規模、佔有率、成長分析，按類型、部署模式、最終用戶 - 產業預測，2023-2030年

Global Digital Vaccine Market Size, Share, Growth Analysis, By Type, By Deployment mode, By End user - Industry Forecast 2023-2030
出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球數位疫苗市場規模為16.976億美元，從2023年的18.7858億美元成長到2031年的42.2427億美元，預計在預測期內（2024-2031年）年複合成長率為10.66%。

數位疫苗目的是透過虛擬實境、智慧型手機應用程式和人工智慧等創新數位技術，採用神經認知訓練和助推策略來改變行為並改善身心健康。這些先進的工具目的是訓練大腦並培養積極的習慣，提供價格實惠、易於使用的解決方案，適應廣泛的需求，能夠接觸到廣泛的人群並發揮作用，提供有針對性的支持。透過整合神經認知訓練和助推策略，數位疫苗具有灌輸更健康行為和豐富生活的巨大潛力。醫療保健 IT 的進步以及物聯網、穿戴式科技、元宇宙平台和擴增實境概念的興起改變數位疫苗格局。這些創新將促進對各種疾病和恐懼症進行更頻繁的干涉，美國國防部開發的虛擬創傷後壓力症候群體驗等措施就是例證。此外，人工智慧和機器學習擴大整合到數位疫苗管理系統中，以提高無針疫苗治療多種病理的準確性和有效性。此外，人工智慧和機器學習在目的是促進年輕人健康生活方式的視訊遊戲和行動應用程式的開發中也發揮關鍵作用。這種開創性的數位疫苗已獲得美國專利，基於人工智慧驅動的化身。

自上而下和自下而上的方法已用於估計和檢驗全球數位疫苗市場的規模，並估計其他各個相關子市場的規模。用於估計市場規模的調查方法包括以下詳細資訊：用於確定市場主要企業的二次研究，用於確定每個地區的市場佔有率的主要和二次研究。整個過程包括研究主要企業的年度和財務報告以及廣泛的採訪，以獲得執行長、副總裁、董事和行銷負責人等行業領導者的重要見解。所有佔有率比率和細節均使用二手資訊確定並使用主要資訊檢驗。本研究涵蓋的所有可能影響市場的參數都經過詳細考慮，並透過初步研究檢驗並進行分析，以獲得最終的定量和定性資料。

數位疫苗全球細分市場分析

全球數位疫苗市場根據類型、部署模式、最終用戶和地區進行細分。依類型分類，市場分為疫苗管理軟體、疫苗接種追蹤應用程式和數位平台。依部署模式，市場分為雲端基礎的和本地的。依最終用戶分類，市場分為醫療保健提供者、製藥和生物技術公司、政府和上市公司、研究機構和學術中心以及患者和看護者。依地區分類，分為北美、歐洲、亞太地區、中東、非洲、拉丁美洲。

數位疫苗的全球市場促進因素

世界各地的政府和醫療機構越來越重視疫苗接種工作，將其視為對抗傳染病傳播的關鍵策略。這種日益增加的關注產生了對能夠簡化和最佳化免疫工作的技術疫苗解決方案的巨大需求。世界衛生組織（WHO）的全球疫苗行動計畫透過努力提高疫苗接種覆蓋率和促進公平的疫苗取得來強調這一需求。透過利用行動應用程式等數位資源來安排預約和發送提醒，醫療保健提供者可以有效地與目標受眾建立聯繫並提高疫苗接種率。

全球數位疫苗市場的限制因素

管理數位疫苗系統中的敏感健康資料引起了對資料隱私和安​​全的擔憂，並強調了保護個人健康資訊和維護免疫記錄機密性的重要性。如果沒有有效的安全措施，資料外洩和未授權存取的可能性就會增加。解決這些問題並實施嚴格的資料保護通訊協定對於獲得公眾信任和普及數位疫苗解決方案的採用非常重要。

全球數位疫苗市場趨勢

在疫苗供應鏈中利用區塊鏈技術提供了去中心化、防篡改的帳本系統，大幅提高了安全性和透明度。透過區塊鏈，相關人員可以確保疫苗的真實性和可追溯性，減少替代品的威脅，並確保供應鏈每個階段的適當儲存和處理。 IBM 的「疫苗區塊鏈」舉措就體現了這一點，利用區塊鏈來監控疫苗從生產到管理的整個過程，提供清晰且審核的疫苗軌跡。

目錄

  • 執行摘要
  • 調查方法
  • 母市場分析
  • 主要市場考察
    • 技術分析
    • 價格分析
    • 供應鏈分析
    • 價值鏈分析
    • 市場生態系統
    • 智慧財產權分析
    • 貿易分析
    • Start-Ups分析
    • 原料分析
    • 創新矩陣
    • 研發線產品分析
    • 總體經濟指標
    • 主要投資分析
    • 關鍵成功因素
    • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 課題
    • 監管形勢
    • 波特的分析
    • 對未來顛覆的特別見解
  • 全球數位疫苗市場：依類型
    • 市場概況
    • 疫苗管理軟體
    • 疫苗接種追蹤應用
    • 和數位平台
  • 全球數位疫苗市場：依部署模式
    • 市場概況
    • 雲端基礎和本地
  • 全球數位疫苗市場：依最終用戶分類
    • 市場概況
    • 醫護人員
    • 製藥和生物技術公司
    • 政府和公共衛生機構
    • 研究機構和學術中心
    • 以及患者和看護者
  • 全球數位疫苗市場規模：依地區
    • 市場概況
    • 北美洲
      • 美國
      • 加拿大
    • 歐洲
      • 德國
      • 西班牙
      • 法國
      • 英國
      • 其他歐洲國家地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 拉丁美洲
      • 巴西
      • 其他拉丁美洲地區
    • 中東和非洲（MEA）
      • 海灣合作理事會國家
      • 南非
      • 其他中東、非洲地區
  • 競爭形勢
    • 前5名企業對比
    • 主要企業市場定位（2021年）
    • 主要市場參與者所採取的策略
    • 關鍵成功策略
    • 近期市集活動
    • 主要企業市場佔有率（2021年）
  • 主要企業簡介
    • Pfizer Inc.（US）
    • Moderna, Inc.（US）
    • Johnson & Johnson Services, Inc.（US）
    • AstraZeneca PLC（UK）
    • Novavax, Inc.（US）
    • GlaxoSmithKline PLC（UK）
    • Sanofi SA（France）
    • Merck & Co., Inc.（US）
    • BioNTech SE（Germany）
    • Sinovac Biotech Ltd.（China）
    • Bharat Biotech（India）
    • Serum Institute of India Pvt. Ltd.（India）
    • CanSino Biologics Inc.（China）
    • Daiichi Sankyo Company, Limited（Japan）
    • CureVac AG（Germany）
    • Takeda Pharmaceutical Company Limited（Japan）
    • Valneva SE（France）
    • Janssen Pharmaceutica NV（Belgium）
    • CSL Limited（Australia）
    • Dynavax Technologies Corporation（US）
簡介目錄
Product Code: SQMIG35G2197

Global Digital Vaccine Market size was valued at USD 1697.60 million in 2022 and is poised to grow from USD 1878.58 million in 2023 to USD 4224.27 million by 2031, growing at a CAGR of 10.66% during the forecast period (2024-2031).

The aim of Digital Vaccines is to modify behaviors and improve mental and physical well-being by employing neurocognitive training and nudging tactics through innovative digital technologies like virtual reality, smartphone apps, and artificial intelligence. These advanced tools are designed to train the brain and foster positive habits, offering affordable, user-friendly solutions adaptable to diverse needs, thereby reaching a wide audience and providing targeted assistance. By integrating neurocognitive training and nudging strategies, digital vaccines hold great promise for instilling healthier behaviors and enriching lives. The landscape of digital vaccines has undergone a transformation propelled by advancements in healthcare IT and the rise of concepts like the Internet of Things, wearable technology, metaverse platforms, and augmented reality. These innovations facilitate more frequent interventions for various diseases and phobias, exemplified by initiatives like the Virtual PTSD Experience developed by the US Department of Defense. Moreover, artificial intelligence and machine learning are increasingly integrated into digital vaccine management systems to enhance the precision and efficacy of needle-free vaccines for treating diverse conditions. Additionally, AI and machine learning play a crucial role in the development of video games and mobile applications aimed at promoting healthy lifestyles among young individuals. The pioneering digital vaccine to receive a US patent relies on AI-driven avatars as its cornerstone.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Vaccine Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Vaccine Market Segmental Analysis

Global Digital Vaccine Market is segmented on the basis of type, deployment mode, end user, and region. By type, the market is segmented into vaccine management software, vaccination tracking applications, and digital platforms. By deployment mode, the market is segmented into cloud-based and on-premise. By end user, the market is segmented into healthcare providers, pharmaceutical & biotechnology companies, government & public health agencies, research institutes & academic centers, and patients & caregivers. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Digital Vaccine Market

Governments and healthcare institutions globally are increasingly prioritizing immunization initiatives as a crucial strategy to combat the transmission of contagious illnesses. This intensified attention has spurred a significant need for technological vaccine solutions capable of streamlining and optimizing vaccination efforts. The World Health Organization's (WHO) Global Vaccine Action Plan underscores this imperative by striving to bolster vaccination rates and promote equitable vaccine accessibility. Leveraging digital resources like mobile applications for scheduling appointments and sending reminders can empower healthcare providers to efficiently connect with and mobilize target demographics, thereby bolstering vaccination coverage rates.

Restraints in the Global Digital Vaccine Market

The management of sensitive health data within digital vaccine systems prompts worries regarding data privacy and security, emphasizing the importance of safeguarding personal health information and upholding the confidentiality of vaccination records. Without effective security measures, the potential for data breaches and unauthorized access heightens. To instill public trust and promote the widespread acceptance of digital vaccine solutions, it is imperative to address these concerns and enforce rigorous data protection protocols.

Market Trends of the Global Digital Vaccine Market

Utilizing blockchain technology in vaccine supply chains provides a decentralized and tamper-proof ledger system, significantly improving security and transparency. Through blockchain, stakeholders can guarantee the authenticity and traceability of vaccines, mitigating the threat of counterfeit goods and ensuring appropriate storage and handling at every stage of the supply chain. IBM's "Blockchain for Vaccines" initiative exemplifies this, employing blockchain to monitor vaccines from production to administration, furnishing a clear and auditable account of the vaccine's trajectory.

Table of Contents

  • Executive Summary
    • Market Overview
    • Wheel of Fortune
  • Research Methodology
    • Information Procurement
    • Secondary & Primary Data Sources
    • Market Size Estimation
    • Market Assumptions & Limitations
  • Parent Market Analysis
    • Market Overview
    • Market Size
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Key Market Insights
    • Technology Analysis
    • Pricing Analysis
    • Supply Chain Analysis
    • Value Chain Analysis
    • Ecosystem of the Market
    • IP Analysis
    • Trade Analysis
    • Startup Analysis
    • Raw Material Analysis
    • Innovation Matrix
    • Pipeline Product Analysis
    • Macroeconomic Indicators
    • Top Investment Analysis
    • Key Success Factor
    • Degree of Competition
  • Market Dynamics & Outlook
    • Market Dynamics
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
    • Regulatory Landscape
    • Porters Analysis
      • Competitive rivalry
      • Threat of Substitute Products
      • Bargaining Power of Buyers
      • Threat of New Entrants
      • Bargaining Power of Suppliers
    • Skyquest Special Insights on Future Disruptions
      • Political Impact
      • Economic Impact
      • Social Impact
      • Technical Impact
      • Environmental Impact
      • Legal Impact
  • Global Digital Vaccine Market by Type
    • Market Overview
    • Vaccine management software
    • vaccination tracking applications
    • and digital platforms
  • Global Digital Vaccine Market by Deployment mode
    • Market Overview
    • Cloud-based and on-premise
  • Global Digital Vaccine Market by End user
    • Market Overview
    • Healthcare providers
    • pharmaceutical & biotechnology companies
    • government & public health agencies
    • research institutes & academic centers
    • and patients & caregivers
  • Global Digital Vaccine Market Size by Region
    • Market Overview
    • North America
      • USA
      • Canada
    • Europe
      • Germany
      • Spain
      • France
      • UK
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia-Pacific
    • Latin America
      • Brazil
      • Rest of Latin America
    • Middle East & Africa (MEA)
      • GCC Countries
      • South Africa
      • Rest of MEA
  • Competitive Landscape
    • Top 5 Player Comparison
    • Market Positioning of Key Players, 2021
    • Strategies Adopted by Key Market Players
    • Top Winning Strategies
      • By Development
      • By Company
      • By Year
    • Recent Activities in the Market
    • Key Companies Market Share (%), 2021
  • Key Company Profiles
    • Pfizer Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Moderna, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Johnson & Johnson Services, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • AstraZeneca PLC (UK)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Novavax, Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • GlaxoSmithKline PLC (UK)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Sanofi S.A. (France)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Merck & Co., Inc. (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • BioNTech SE (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Sinovac Biotech Ltd. (China)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Bharat Biotech (India)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Serum Institute of India Pvt. Ltd. (India)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • CanSino Biologics Inc. (China)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Daiichi Sankyo Company, Limited (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • CureVac AG (Germany)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Takeda Pharmaceutical Company Limited (Japan)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Valneva SE (France)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Janssen Pharmaceutica NV (Belgium)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • CSL Limited (Australia)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments
    • Dynavax Technologies Corporation (US)
      • Company Overview
      • Business Segment Overview
      • Financial Updates
      • Key Developments